Human colon cancers that lack APC mutations frequently have activating mutations in CTNNB1 (β-catenin) that prevent its phosphorylation by GSK-3, demonstrating a key epistatic relationship between APC and CTNNB1/β-catenin [130,131]. Here, CTNNB1 is linked to malignant colon neoplasm.